טוען...
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
Human schistosomiasis is a disease which globally affects over 229 million people. Three major species affecting humans are Schistosoma mansoni, S. haematobium and S. japonicum. Previous treatment of S. mansoni includes the use of oxamniquine (OXA), a prodrug that is enzymatically activated in S. ma...
שמור ב:
| הוצא לאור ב: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7167500/ https://ncbi.nlm.nih.gov/pubmed/32315953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2020.04.001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|